Government Aims to Expand Investigations on Current Wholesale Transaction Practices

Published: 2005-01-27 07:00:00

Updated: 2005-01-27 07:00:00

In light of a recent discovery of counterfeit antihypertensive Novarsc medications that contain no therapeutic efficacy, the Korea Food and Drug Administration (KFDA) plans to undertake a joint investigative effort with the government prosecutors to examine current wholesale transaction practices...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK